top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Autore Ecke Thorsten
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (240 p.)
Soggetto topico Medicine
Soggetto non controllato adjuvant chemotherapy
androgen receptor
BCG therapy
biomarker
biomarkers
BIRC5
bladder
bladder cancer
bladder cancer detection
cadmium exposure
cancer
chemotherapy
combination therapy
DNA methylation
drug resistance
ECRG4
ERBB2
F-actin
FGFR3
grade
heparan sulfate proteoglycans (HSPGs)
heparanase
histone demethylase
immunotherapy
invasion
ITIH5
JAK inhibitor
JAK-STAT pathway
KDM7A
KRT20
macrophage
metabolomics
Metallothionein
MIBC
miRNA
MS
muscle-invasive bladder cancer
n/a
NMR
non muscle invasive bladder cancer
non-invasive detection
oncolytic adenovirus
p53
personalized medicine
prediction
predictive biomarker
prognosis
proliferation
PTEN
quantitative PCR
RT-qPCR
somatic mutations
STAT3/5 inhibitor
survival
survivin
syndecan-1
TAGLN
TC-E 5002
telomerase
TERT promoter mutations
TERT promoter region
tumor marker
tumor markers
tumorigenesis
urinary biomarkers
urothelial cancer
urothelial carcinoma
urothelium
virotherapy
voided urine cytology
XVir-N-31
zinc transporter
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557142003321
Ecke Thorsten  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Integrating Clinical and Translational Research Networks-Building Team Medicine
Integrating Clinical and Translational Research Networks-Building Team Medicine
Autore Salgia Ravi
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (250 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato academic and community oncology
academic cancer center
actionable mutations
adjuvant chemotherapy
bladder cancer
breast cancer
cancer care plans
cancer center
cancer clinical trials
cancer genetics
cancer genomics
cancer prevention
clinical research
clinical trials
colorectal cancer
community
community oncology
community practice
concurrent chemoradiation therapy
COVID-19
driver mutations
Early Recovery After Surgery (ERAS)
epithelial ovarian cancer
ethnicity
fast-and-frugal trees
feeding tube dependency
frontline treatment
genetics counseling
geriatric oncology
HER2-directed therapy
human papillomavirus
immunotherapy
integrated cancer care
low-dose CT scans
lung cancer
lung cancer screening
maintenance therapy
minorities
n/a
national guidelines for screening and prevention
next-generation sequencing
non-small cell lung cancer
older adults
oncology medical home
oncology pathways
oropharyngeal cancer
PARP inhibitor
personalized medicine
pharmaceutical aids to smoking cessation
precisian medicine
precision medicine
race
receptor tyrosine kinases
recruitment
renal cell carcinoma
research
small cell lung cancer
smoking cessation
supportive care pathways
surgical debulking
surgical pathways
team medicine
team science
team-based care
team-based medicine
testing rates
tobacco control
translational research
urothelial carcinoma
value-based cancer care
value-based care
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557124403321
Salgia Ravi  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
Autore Uchino Junji
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (258 p.)
Soggetto topico Medicine
Soggetto non controllato adjuvant chemotherapy
biomarker
chemotherapy
daily practice
DNA polymerase beta
docetaxel
EGFR-TKI
endocrine disorders
epidermal growth factor receptor
Expanded Access Program
FDG-PET
genomic diagnosis
glucose transporter 1
HIP1R
immune checkpoint inhibitor
immune checkpoint inhibitors
immune-related adverse events
immunotherapy
interstitial lung disease
KRAS
lung cancer
lung neoplasms
meta-analysis
metastasis
methylation
multiple cancers
mutation
network meta-analysis
nivolumab
non-small cell lung cancer
non-small-cell lung cancer
nonsmall cell lung cancer
NSCLC
nucleotide-diphosphate kinase
oligometastasis
osimertinib
PD-1
PD-1 blockade
PD-1 inhibitors
PD-L1
PD-L1 expression
PD-L1 inhibitors
phase I/II trial
platinum-based first-line
predictive biomarker
previously treated patients
prognosis
prognostic factor
prognostic factors
pulmonary fibrosis
pulmonary pleomorphic carcinoma
RAD51B methylation
radiology and other imaging
real-world data
rechallenge
recurrence
responsiveness
retrospective analysis
RUNX1
S-1
salvage surgery
sequencing
stage IIIA-N2
surgery
survival
T790M
targeted therapy
TP53 mutations
tumor-bearing patients
tyrosine kinase inhibitors
unresectable
β-catenin
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Non-small Cell Lung Cancer
Record Nr. UNINA-9910557489703321
Uchino Junji  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Precision Medicine in Solid Tumors
Precision Medicine in Solid Tumors
Autore Dey Nandini
Descrizione fisica 1 online resource (304 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato adjuvant chemotherapy
anaplastic lymphoma receptor tyrosine kinase
breast cancer
cancer
cancer-associated fibroblasts
cfDNA
chemotherapy
circulating free DNA
clinical guideline
clonality classification
comprehensive genomic profiling
CTC
ctDNA
DDR genes
Decision tree
digital enrichment
driver mutation
EGFR mutation
EGFR-TKI
electronic records
epidermal growth factor receptor
extent of resection
gene panel sequencing
glioblastoma prognosis
HNSCC
immune checkpoint inhibitors
immunocytochemistry
immunotherapy
intratumor heterogeneity
laboratory-friendly
liquid biopsy
molecular barcoding
molecular genotyping
multiple biopsies
n/a
new drug development
next-generation sequencing
next-generation sequencing (NGS)
NGS
non-small cell lung cancer
open data
osimertinib
outcome
overall survival
parallel double-detection
PARP inhibitors
PD-L1
pediatric tumors
personalized precision oncology
precision medicine
presumed germline findings
random forest
regulatory reform
resistance
screening
sequencing
smoking
solid cancer
strategic therapeutic intervention
targeted therapy
tDNA
thymoma
TMB
TNBC subtypes
triple-negative breast cancer (TNBC)
tumor evolution
tumor mutational burden
tumor profiling test
tyrosine kinase inhibitor
universal health-care system
whole-exome sequencing
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910595078103321
Dey Nandini  
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Autore Satoi Sohei
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (214 p.)
Soggetto topico Medicine and Nursing
Surgery
Soggetto non controllato adjuvant chemotherapy
arterial resection
biliary drainage
borderline resectable
branch duct intraductal papillary mucinous neoplasm
cell-free DNA
chemoradiotherapy
clinical staging
conversion surgery
early recurrence
ERAS
high grade dysplasia
intraductal papillary mucinous neoplasm
invasive carcinoma
isolated local recurrence
laparoscopic
lymph node dissection
malignancy
mesopancreas
meta-analysis
n/a
neoadjuvant therapy
neoadjuvant treatment
nerve and fibrous tissues
pancreatectomy
pancreatic cancer
pancreatic cystic neoplasm
pancreatic ductal adenocarcinoma
pancreatic exocrine insufficiency
pancreatic main duct dilatation
pancreatic neoplasm/analysis
pancreatic neoplasm/surgery
pancreatic remnant
pancreaticoduodenectomy
prehabilitation
prognostic nutritional index
R0 resection
recurrence
redo surgery
risk factor
superior mesenteric artery
surgical treatment
survival
technical advances
total pancreatectomy
tumor location
unresectable pancreatic ductal adenocarcinoma
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557364803321
Satoi Sohei  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui